1-O-octadecyl-2-arachidonoyl-sn-glycero-3-phosphocholine

Metabolite details

Identifier

GBNPCIWXLWZJGA-IGBSIYCFSA-N

InChI Key

GBNPCIWXLWZJGA-IGBSIYCFSA-N

IUPAC name

(2R)-2-{[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxy}-3-(octadecyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

1-O-octadecyl-2-arachidonoyl-sn-glycero-3-phosphocholine

INN name

—

Synonym

PC(O-18:0/20:4(5Z,8Z,11Z,14Z))

ChEBI

CHEBI:75245

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
• Metabolic characterization of the natural progression of chronic hepatitis B (Lipid assays).
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium

Observed in differential profiles

• non_COVID_19_healthy_vs_non_critical_COVID_19
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Knockdown_vs_Control
• Knockdown_vs_Control
• wild_type_vs_patA_deletion